• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Okadaic Acid Sodium

Okadaic Acid Sodium

Product ID O4104
Cas No. 209266-80-8
Purity ≥98%
Product Unit SizeCostQuantityStock
25 µg $218.00 In stock
100 µg $324.50 In stock
1 mg $1,622.40 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Okadaic acid is a diarrhetic shellfish toxin initially produced by dinoflagellates and sea sponges; it exhibits neurotoxic and anticancer activities. Okadaic acid inhibits protein phosphatases 1 and 2A (PP1, PP2A). In animal models of Alzheimer’s disease, okadaic acid increases phosphorylation of tau protein. In adipocytes, this compound stimulates lipolysis by increasing phosphorylation of perilipin A and B. In T cell leukemia cells, okadaic acid induces G1 phase cell cycle arrest, decreases expression of cyclin D2, CDK4, CDK6, Bcl-2, Bcl-xl, and XIAP, increases expression of p21 and p27, activates caspases, and inhibits cell growth.

 

Product Info

Cas No.

209266-80-8

Purity

≥98%

Formula

C44H67O13Na

Formula Wt.

827.0

Chemical Name

9,10-Deepithio-9,10-didehydroacanthifolicin sodium salt

Melting Point

164-166°C

Solubility

Soluble in ethanol, DMSO, or water.

Appearance

White crystal solid or clear colorless solid film

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

O4104 MSDS PDF

Info Sheet

O4104 Info Sheet PDF

References

Hendrickson O, Mukhametova L, Zvereva E, et al. A sensitive fluorescence polarization immunoassay for the rapid detection of okadaic acid in environmental waters. Biosensors (Basel). 2023 Apr 16;13(4):477. PMID: 37185552.

Kamat PK, Rai S, Swarnkar S, et al. Molecular and Cellular Mechanism of Okadaic Acid (OKA)-Induced Neurotoxicity: A Novel Tool for Alzheimer's Disease Therapeutic Application. Mol Neurobiol. 2014 Apr 8. [Epub ahead of print]. PMID: 24710687.

Chang NC, Lin AC, Hsu CC, et al. Okadaic Acid, a Bioactive Fatty Acid from Halichondria okadai, Stimulates Lipolysis in Rat Adipocytes: The Pivotal Role of Perilipin Translocation. Evid Based Complement Alternat Med. 2013;2013:545739. PMID: 24319476.

Mori N, Ishikawa C, Uchihara JN, et al. Protein phosphatase 2A as a potential target for treatment of adult T cell leukemia. Curr Cancer Drug Targets. 2013 Oct;13(8):829-42. PMID: 24015987.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • F4584

    Fluphenazine Hydrochloride

    Piperazine; FIASMA, D2 antagonist, hERG K+ chan...

    ≥97%
  • P7628

    Parathyroid Hormone-Related Protein (1-34), human/rat

    Endogenous peptide hormone, increases extracell...

    ≥95%
  • N859614

    NVP-LDE225

    Smo inhibitor.

    ≥98%
  • C577524

    Concanamycin A

    Macrolide lactone antibiotic.

    ≥98%
  • V1668

    Vemurafenib

    B-Raf inhibitor.

    ≥98%
  • S0168

    Saracatinib

    Src and Abl inhibitor.

    ≥98%
  • T7158

    Tropicamide

    mAChR antaonist.

    ≥98%
  • H014458

    Halometasone

    Glucocorticoid

    ≥98%
  • L920000

    LX-2343

    Promotes Aβ clearance.

    ≥98%
  • P200600

    PF-06873600

    CDK2/4/6 inhibitor

    ≥98%
  • D183745

    Destruxin B

    Cyclic depsipeptide is a secondary metabolite i...

    ≥96%
  • A5134

    Aminophylline Anhydrous

    Adenosine antagonist, PDE inhibitor.

    ≥98%
  • T0216

    TAE-226

    FAK inhibitor.

    ≥98%
  • A484091

    Amcinonide

    Glucocorticoid

    ≥98%
  • C9673

    Cysteamine Hydrochloride

    Aminothiol, CoA component; ulcer inducer.

    ≥99%
  • C0271

    Carfilzomib

    Epoxomicin analog; proteasome inhibitor.

    ≥98%
  • S0245

    Salmeterol

    β2-adrenergic agonist.

    ≥98%
  • D3219

    Diflubenzuron

    Benzoylurea, insect growth regulator; chitin sy...

    ≥95%
  • E6235

    Epirubicin Hydrochloride

    Anthracycline, DNA intercalator; topoisomerase ...

    ≥90%
  • T6931

    Triclosan

    Diarylether; bacterial ENR binder, fatty acid s...

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only